the problem with ovas is that they are 2nd option after IVF. They are not worth 400m as 2nd option. Value will only go up if they become 1st option, and that can only happen with Overture, which is still some time away from commercialization.
no you don't understand it. Augment cost 15k....IVF cost the same. No one is doing both together. Only people who have failed multiple IVFs go for Augment.
And BTW, Augment is not approved in US.
is about $400M market cap at $3. Remember we still have to do Ph 2B.
$3 is still almost a double from here. If you want AXON type valuation, AVXL needs to show strong 2B too. And remember those warrants.
So I see market cap about 1Billion by late of 2016. A double after 2A. Stock price may not double due to warrants, but still big move.
This talk about $10-$15 in 2015 is not real.
I also expect dilution sometime 2016 for them to prepare for Phase 3 trials.
So my prediction -
Early Nov before conference - over $2.
After 2A results - $2.75 - $3.
Dilution in 2016.
Price in 2016 before 2B - $4.
Price in 2016 after 3B - $6-7.
At $7 we are already at $1Billion market cap.
yes 6-7 after 2b. That is correct. If 2b is going well they will definitely dilute in 2016, to raise cash for ph 3 preparation. So this is pump up market cap without price. Also don't forget warrants that will be sold when 2A bump happens to around $2.75.
As for epilepsy, parkinsons etc. those are just preclinical and phase 1. So not much value right now. And they don't have funds to proceed with moving these further. Their focus is going to be AD only.
Of course, if a big pharma comes in and funds them for eplipsy/pk, that is a different story.
Guys lets be realistic. This talk about $10-15 in 2015 is not going to happen.
pumping the stock is fine, but c'mon talk about 30-40 billion market cap in 2016 ?? without even phase 3 complete ??? who is on the pipe now.
I am long, not short. But I am doing some level setting here. Still feel a 100% gain from today in 8-10 months is a great trade in AVXL. People here feel we are looking at 1000% gain in 1 year from now. That is not realistic.
price will be above 2 before report....could jump to that next week, and then trend sideways for 2-3 weeks.
if IBB continues to rise, so will AVXL..if IBB pulls back, AVXL may a bit too. But end of week it will be higher than 1.60. Getting ready for Nov 7th.
market cap 1.3 billion...buy AVXL for 3x current market cap.
why bother ? He is doing it because he knows its going to be GREAT. And funds only buy stocks over $5, and not on pink OTC. He is preparing for the future. He says it himself - uplisting is for sharing into the future success.
we are doing the reverse..we are moving up because fundamentals are getting much better....
when they disclose results on Nov 7.
If he knows results are not going to be good, he would not be flying so many people to Barcelona, or do the R/S.
He know with great results, stock will do much better on NAS and over $5 where funds will buy.
why would he fly doctor from Austrialia to Barcelona to present the results ? All this means results for 2A part A and B will be really good. Read between the leaves.